Search Results - "TERAMI, Takahiro"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2
  3. 3

    Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray by Inoue, Kentaro, Wada, Jun, Eguchi, Jun, Nakatsuka, Atsuko, Teshigawara, Sanae, Murakami, Kazutoshi, Ogawa, Daisuke, Terami, Takahiro, Katayama, Akihiro, Tone, Atsuhito, Iseda, Izumi, Hida, Kazuyuki, Yamada, Masao, Ogawa, Tomohisa, Makino, Hirofumi

    Published in PloS one (15-10-2013)
    “…We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy by Watanabe, Mayu, Nakatsuka, Atsuko, Murakami, Kazutoshi, Inoue, Kentaro, Terami, Takahiro, Higuchi, Chigusa, Katayama, Akihiro, Teshigawara, Sanae, Eguchi, Jun, Ogawa, Daisuke, Watanabe, Eijiro, Wada, Jun, Makino, Hirofumi

    Published in PloS one (25-03-2014)
    “…Phosphatidylethanolamine N-methyltransferase (Pemt) catalyzes the methylation of phosphatidylethanolamine (PE) to phosphatidylcholine (PC) mainly in the liver…”
    Get full text
    Journal Article
  6. 6

    Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease by Kurose, Yuko, Wada, Jun, Kanzaki, Motoko, Teshigawara, Sanae, Nakatsuka, Atsuko, Murakami, Kazutoshi, Inoue, Kentaro, Terami, Takahiro, Katayama, Akihiro, Watanabe, Mayu, Higuchi, Chigusa, Eguchi, Jun, Miyatake, Nobuyuki, Makino, Hirofumi

    Published in BMC nephrology (22-01-2013)
    “…Galectin-9 (Gal-9) induces apoptosis in activated T helper 1 (TH1) cells as a ligand for T cell immunoglobulin mucin-3 (Tim-3). Gal-9 also inhibits the G1…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins by Kanzaki, Motoko, Wada, Jun, Nakatsuka, Atsuko, Teshigawara, Sanae, Murakami, Kazutoshi, Inoue, Kentaro, Terami, Takahiro, Katayama, Akihiro, Nasu, Junichiro, Yamamoto, Kazuhide, Makino, Hirofumi

    Published in Internal Medicine (01-01-2012)
    “…Although the appearance of abnormal lipoproteins in liver diseases is well known, the precise analyses of abnormal lipoproteins remain elusive. Here, we report…”
    Get full text
    Journal Article
  9. 9

    Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes by Kanzaki, Motoko, Wada, Jun, Sugiyama, Koichi, Nakatsuka, Atsuko, Teshigawara, Sanae, Murakami, Kazutoshi, Inoue, Kentaro, Terami, Takahiro, Katayama, Akihiro, Eguchi, Jun, Akiba, Hisaya, Yagita, Hideo, Makino, Hirofumi

    Published in Endocrinology (Philadelphia) (01-02-2012)
    “…Galectin-9 (Gal-9), a ligand for T cell Ig mucin-3 (Tim-3), induces apoptosis in cluster of differentiation 4 (CD4)+ Tim-3+ T helper 1 (TH1) cells via the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes by Terami, Takahiro, Wada, Jun, Inoue, Kentaro, Nakatsuka, Atsuko, Ogawa, Daisuke, Teshigawara, Sanae, Murakami, Kazutoshi, Katayama, Akihiro, Eguchi, Jun, Makino, Hirofumi

    “…Urinary angiotensinogen has been reported as a marker for the activation of intrarenal renin-angiotensin system (RAS) in various kidney diseases. To…”
    Get full text
    Journal Article
  14. 14

    Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray: e77118 by Inoue, Kentaro, Wada, Jun, Eguchi, Jun, Nakatsuka, Atsuko, Teshigawara, Sanae, Murakami, Kazutoshi, Ogawa, Daisuke, Terami, Takahiro, Katayama, Akihiro, Tone, Atsuhito

    Published in PloS one (01-10-2013)
    “…We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to…”
    Get full text
    Journal Article
  15. 15
  16. 16